Insider Trading Arrangements

3 Months Ended

12 Months Ended

Dec. 31, 2023

shares

Dec. 31, 2023

shares

Trading Arrangements, by Individual

Material Terms of Trading Arrangement

From time to time, our officers (as defined in Rule 16a–1(f)) and directors may enter into Rule 10b5-1 or non-Rule 10b5-1 trading arrangements (as each such term is defined in Item 408 of Regulation S-K). During the three months

ended December 31, 2023, our officers and directors took the following actions with respect to 10b5-1 trading arrangements:

			Trading Arrangement
	Action	Date	Type of Trading Arrangement	Nature of Trading Arrangement	Total Shares to be Sold	Expiration Date
Natarajan Sethuraman (Chief Scientific Officer)	Adopt	12/14/2023	Trading plan intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c)	Sale of the Company's common stock pursuant to the terms of the plan	33,856 (1)	4/13/2025

(1)Subject to increase based on any shares not sold under a previous 10b5-1 plan which will expire in April of 2024.

Non-Rule 10b5-1 Arrangement Adopted

false

Rule 10b5-1 Arrangement Terminated

false

Non-Rule 10b5-1 Arrangement Terminated

false

Natarajan Sethuraman [Member]

Trading Arrangements, by Individual

Name

Natarajan Sethuraman

Title

Chief Scientific Officer

Rule 10b5-1 Arrangement Adopted

true

Adoption Date

12/14/2023

Arrangement Duration

486 days

Aggregate Available

33,856

33,856